These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
5. Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy. Byrnes AA; Harris DM; Atabani SF; Sabundayo BP; Langan SJ; Margolick JB; Karp CL J Leukoc Biol; 2008 Dec; 84(6):1447-53. PubMed ID: 18806124 [TBL] [Abstract][Full Text] [Related]
6. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. Prince HE; Kleinman S; Czaplicki C; John J; Williams AE J Acquir Immune Defic Syndr (1988); 1990; 3(5):525-30. PubMed ID: 1969960 [TBL] [Abstract][Full Text] [Related]
8. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II. Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824 [TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases. Schuster V; Herold M; Wachter H; Reibnegger G Infection; 1993; 21(4):210-3. PubMed ID: 8225623 [TBL] [Abstract][Full Text] [Related]
10. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis. Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
12. Comparison of lymphocyte subpopulations in the peripheral blood of patients with infectious mononucleosis and human immunodeficiency virus infection: a preliminary report. Zidovec S; Culig Z; Begovac J; Jeren T J Clin Lab Immunol; 1998; 50(2):63-9. PubMed ID: 10470624 [TBL] [Abstract][Full Text] [Related]
13. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome. Marcante R; Cavedon G Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953 [TBL] [Abstract][Full Text] [Related]
14. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection. Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841 [TBL] [Abstract][Full Text] [Related]
15. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. Mikyas Y; Aziz N; Harawa N; Gorre M; Neagos N; Nogueira M; Wafer D; Dillon M; Boyer PJ; Bryson YJ; Plaeger S J Reprod Immunol; 1997 Jun; 33(2):157-70. PubMed ID: 9234214 [TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation. Diez-Ruiz A; Kaiser G; Jäger H; Birkmann J; Tilz GP; Wachter H; Fuchs D Int Arch Allergy Immunol; 1993; 102(1):56-60. PubMed ID: 8104576 [TBL] [Abstract][Full Text] [Related]
17. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640 [TBL] [Abstract][Full Text] [Related]
18. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS. Reddy MM; McKinley G; Englard A; Grieco MH Int J Immunopharmacol; 1990; 12(7):737-41. PubMed ID: 2127261 [TBL] [Abstract][Full Text] [Related]
19. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]